CITIGROUP INC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$10,000
-44.4%
10,000
-44.4%
0.00%
Q2 2021$18,000
+125.0%
18,000
+125.0%
0.00%
Q1 2021$8,0000.0%8,000
+14.3%
0.00%
Q4 2020$8,0000.0%7,000
-12.5%
0.00%
Q3 2020$8,000
-11.1%
8,0000.0%0.00%
Q2 2020$9,000
+28.6%
8,000
+14.3%
0.00%
Q1 2020$7,000
-92.1%
7,000
-91.0%
0.00%
Q4 2019$89,000
-20.5%
78,000
-20.4%
0.00%
Q3 2019$112,000
-84.9%
98,000
-82.2%
0.00%
-100.0%
Q1 2019$744,000
+40.9%
550,000
+10.0%
0.00%
Q4 2017$528,000
-84.7%
500,000
-84.7%
0.00%
-100.0%
Q3 2017$3,452,000
+146.6%
3,268,000
+147.6%
0.00%
+200.0%
Q2 2017$1,400,000
-41.5%
1,320,000
-46.9%
0.00%
-50.0%
Q1 2017$2,392,000
+963.1%
2,484,000
+1013.9%
0.00%
Q4 2016$225,000
+1025.0%
223,000
+1138.9%
0.00%
Q4 2015$20,00018,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders